3bae

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px <!-- The line below this paragraph, containing "STRUCTURE_3bae", creates the "Structure Box" on the page. You may change the PDB parameter (which sets the PD...)
Line 1: Line 1:
-
[[Image:3bae.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:3bae.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_3bae| PDB=3bae | SCENE= }}
{{STRUCTURE_3bae| PDB=3bae | SCENE= }}
-
'''Crystal structure of Fab WO2 bound to the N terminal domain of Amyloid beta peptide (1-28)'''
+
===Crystal structure of Fab WO2 bound to the N terminal domain of Amyloid beta peptide (1-28)===
-
==Overview==
+
<!--
-
Alzheimer's disease (AD) is the most common form of dementia. Amyloid-beta (A beta) peptide, generated by proteolytic cleavage of the amyloid precursor protein, is central to AD pathogenesis. Most pharmaceutical activity in AD research has focused on A beta, its generation and clearance from the brain. In particular, there is much interest in immunotherapy approaches with a number of anti-A beta antibodies in clinical trials. We have developed a monoclonal antibody, called WO2, which recognises the A beta peptide. To this end, we have determined the three-dimensional structure, to near atomic resolution, of both the antibody and the complex with its antigen, the A beta peptide. The structures reveal the molecular basis for WO2 recognition and binding of A beta. The A beta peptide adopts an extended, coil-like conformation across its major immunodominant B-cell epitope between residues 2 and 8. We have also studied the antibody-bound A beta peptide in the presence of metals known to affect its aggregation state and show that WO2 inhibits these interactions. Thus, antibodies that target the N-terminal region of A beta, such as WO2, hold promise for therapeutic development.
+
The line below this paragraph, {{ABSTRACT_PUBMED_18237744}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 18237744 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_18237744}}
==About this Structure==
==About this Structure==
Line 34: Line 38:
[[Category: Immunotherapy]]
[[Category: Immunotherapy]]
[[Category: Wo2]]
[[Category: Wo2]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Apr 16 23:11:50 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 15:59:32 2008''

Revision as of 12:59, 27 July 2008

Image:3bae.png

Template:STRUCTURE 3bae

Crystal structure of Fab WO2 bound to the N terminal domain of Amyloid beta peptide (1-28)

Template:ABSTRACT PUBMED 18237744

About this Structure

3BAE is a Protein complex structure of sequences from Mus musculus. Full crystallographic information is available from OCA.

Reference

Amyloid-beta-anti-amyloid-beta complex structure reveals an extended conformation in the immunodominant B-cell epitope., Miles LA, Wun KS, Crespi GA, Fodero-Tavoletti MT, Galatis D, Bagley CJ, Beyreuther K, Masters CL, Cappai R, McKinstry WJ, Barnham KJ, Parker MW, J Mol Biol. 2008 Mar 14;377(1):181-92. Epub 2008 Jan 30. PMID:18237744

Page seeded by OCA on Sun Jul 27 15:59:32 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/3bae"
Personal tools